
Rabbit polyclonal antibody detecting active ABL1 (pTyr393) and ABL2 (pTyr429/Tyr439), the activation-loop autophosphorylation sites that mark constitutively active BCR-ABL1 in CML and serve as pharmacodynamic biomarkers for ABL kinase inhibitors. Validated for WB (1:500–1:2,000) and IHC (1:50–1:100) in Human, Mouse, and Rat. ABL1 ~123 kDa · ABL2 ~96 kDa. For Research Use Only.